In Vitro Antibody-Dependent Enhancement Assays Are Insensitive Indicators of in Vivo Vaccine Enhancement of Equine Infectious Anemia Virus

By Raabe M.L.   Issel C.J.   Montelaro R.C.  

Virology, Vol. 259, Iss. 2, 1999-07 ,pp. : 416-427

Elsevier

Access to resources Recommend Favorite

Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus

By Tu Y.-B.   Zhou T.   Yuan X.-F.   Qiu H.-J.   Xue F.   Sun C.-Q.   Wang L.   Wu D.-L.   Peng J.-M.   Kong X.-G.   Tong G.-Z.  

Archives of Virology, Vol. 152, Iss. 1, 2007-01 ,pp. : 209-218

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides

By Cook R.F.   Cook S.J.   Berger S.L.   Leroux C.   Ghabrial N.N.   Gantz M.   Bolin P.S.   Mousel M.R.   Montelaro R.C.   Issel C.J.  

Virology, Vol. 313, Iss. 2, 2003-09 ,pp. : 588-603

Elsevier

Access to resources Recommend Favorite

Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus

By Mealey R.H.   Zhang B.   Leib S.R.   Littke M.H.   McGuire T.C.  

Virology, Vol. 313, Iss. 2, 2003-09 ,pp. : 537-552

Elsevier

Access to resources Recommend Favorite

Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13

By Qi Xu  

Virus Genes, Vol. 41, Iss. 1, 2010-08 ,pp. : 86-98

Springer Publishing Company

Access to resources Recommend Favorite